<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-110339" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Acrodermatitis Chronica Atrophicans</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gade</surname>
            <given-names>Anita</given-names>
          </name>
          <aff>Stamford Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Matin</surname>
            <given-names>Taraneh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rubenstein </surname>
            <given-names>Richard</given-names>
          </name>
          <aff>Medical College of Virginia, Richmond, VA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Robinson</surname>
            <given-names>Carolyn A.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anita Gade declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Taraneh Matin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Richard Rubenstein declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Carolyn Robinson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-110339.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Acrodermatitis chronica atrophicans (ACA) is a late and chronic manifestation of Lyme borreliosis. If untreated, ACA progresses from an early inflammatory stage to a chronic, atrophic phase, which neuropathy, arthralgias, and cutaneous malignancy can complicate. Due to its insidious onset, the diagnosis of ACA is challenging and often delayed. This activity reviews the evaluation and management of ACA and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the etiology of acrodermatitis chronica atrophicans.</p></list-item><list-item><p>Assess&#x000a0;the clinical presentation of a patient with acrodermatitis chronica atrophicans.</p></list-item><list-item><p>Evaluate&#x000a0;the appropriate treatment measures for acrodermatitis chronica atrophicans.</p></list-item><list-item><p>Communicate&#x000a0;the importance of interprofessional collaboration to enhance the care of patients with acrodermatitis chronica atrophicans.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=110339&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=110339">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-110339.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Acrodermatitis chronica atrophicans (ACA) is a late and chronic manifestation of Lyme borreliosis. ACA predominantly involves the distal portions of extremities and is characterized by chronic cutaneous atrophy.<xref ref-type="bibr" rid="article-110339.r1">[1]</xref>&#x000a0;Unlike other skin manifestations of Lyme disease, including erythema migrans and borrelial lymphocytoma, ACA does not spontaneously resolve. If untreated, ACA may progress from bluish-red discoloration and inflammation to chronic atrophy and fibrosis, with the late-stage being more treatment-resistant. ACA was first described in Germany in 1883 by Buchwald, and cases were later reported in North America in 1895.<xref ref-type="bibr" rid="article-110339.r2">[2]</xref>&#x000a0;The diagnosis of ACA is based on clinical presentation, as well as serologic testing and histopathologic confirmation. Recognizing ACA is often challenging due to variable latency in disease onset following the primary borrelial infection and lack of symptoms leading to delay in seeking treatment.&#x000a0;&#x000a0;</p>
        <p>Lyme borreliosis is the most common vector-borne disease in the northeastern United States. It is a multisystem disease caused by the spirochete <italic toggle="yes">Borrelia burgdorferi.</italic><xref ref-type="bibr" rid="article-110339.r3">[3]</xref><xref ref-type="bibr" rid="article-110339.r4">[4]</xref><xref ref-type="bibr" rid="article-110339.r5">[5]</xref><italic toggle="yes">&#x000a0;</italic>It is transmitted to humans via an <italic toggle="yes">Ixodes</italic> tick bite. There are 3 skin manifestations of Lyme borreliosis: erythema migrans (stage 1) with a characteristic &#x0201c;bull&#x02019;s eye rash,&#x0201d; which, if untreated, can be followed by early disseminated infection, borrelial lymphocytoma (stage 2) along with neurologic and cardiac abnormalities, and late infection, especially arthritis in North America or&#x000a0;ACA&#x000a0;(stage 3) in Europe.<xref ref-type="bibr" rid="article-110339.r6">[6]</xref><xref ref-type="bibr" rid="article-110339.r7">[7]</xref><xref ref-type="bibr" rid="article-110339.r8">[8]</xref><xref ref-type="bibr" rid="article-110339.r9">[9]</xref>&#x000a0;ACA is the most common late and chronic manifestation of Lyme borreliosis. Approximately 20% of patients with ACA have a history of spontaneously healed EM, usually on an extremity where the ACA lesion developed 6 months to 8 years later.<xref ref-type="bibr" rid="article-110339.r1">[1]</xref></p>
      </sec>
      <sec id="article-110339.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Borrelia</italic> is a member of the <italic toggle="yes">Spirochaetacea</italic> family. There are approximately 20 different genospecies, but only&#x000a0;5 pose a significant pathogenic risk to humans: <italic toggle="yes">B. afzelii, B. garinii, B. bavariensis, B. burgdorferi </italic>sensu stricto,<italic toggle="yes"> and B. spielmanii.</italic><xref ref-type="bibr" rid="article-110339.r10">[10]</xref><italic toggle="yes">&#x000a0;</italic>ACA results predominantly from bacterial infection with <italic toggle="yes">B. afzelii. </italic>However, it can also be caused by European <italic toggle="yes">B. burgdorferi </italic>sensu stricto or <italic toggle="yes">B. garinii.</italic></p>
      </sec>
      <sec id="article-110339.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>ACA predominantly affects women who are 40-70 years of age. ACA is rare in the pediatric population, with few cases reported in children.<xref ref-type="bibr" rid="article-110339.r11">[11]</xref>&#x000a0;It is more commonly seen in Europe due to untreated infection with <italic toggle="yes">Borrelia afzelii </italic>and is rarely found in the United States. The overall prevalence of ACA in patients with Lyme disease in Europe is approximately 10%.</p>
      </sec>
      <sec id="article-110339.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis of Lyme disease involves the <italic toggle="yes">Ixodes </italic>tick feeding on an infected animal reservoir. The <italic toggle="yes">Borrelia</italic> spirochetes replicate, and some penetrate out of the tick&#x02019;s midgut and migrate to the salivary glands.<xref ref-type="bibr" rid="article-110339.r12">[12]</xref>&#x000a0;When the tick bites a human, it releases spirochetes into the dermis via saliva. This results in an innate immune response with neutrophil migration and macrophage activation, causing the release of pro-inflammatory cytokines. Increased blood flow to the capillaries leads to erythema migrans at the bite site approximately 1 to 2 weeks later.<xref ref-type="bibr" rid="article-110339.r13">[13]</xref>&#x000a0;If untreated, there is hematogenous spread and development of systemic symptoms.&#x000a0;In ACA, a chronic T-cell mediated immune reaction against<italic toggle="yes"> Borrelia </italic>with CD3+ and CD4+ cells in the dermal infiltrate<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-110339.r14">[14]</xref><xref ref-type="bibr" rid="article-110339.r15">[15]</xref>&#x000a0;<italic toggle="yes">Borrelia</italic> binds to extracellular matrix proteins, including glycosaminoglycan-binding protein, fibronectin-binding protein, and decorin proteoglycan.<xref ref-type="bibr" rid="article-110339.r16">[16]</xref><xref ref-type="bibr" rid="article-110339.r17">[17]</xref><xref ref-type="bibr" rid="article-110339.r18">[18]</xref> They activate metalloproteases and cause degradation of the extracellular matrix. <italic toggle="yes">Borrelia</italic> also have a high affinity for collagen fibers, as demonstrated by electron microscopy.<xref ref-type="bibr" rid="article-110339.r19">[19]</xref><xref ref-type="bibr" rid="article-110339.r20">[20]</xref>&#x000a0;Damage to connective tissues, with the destruction of collagen, leads to fibrosis and dermal atrophy.<xref ref-type="bibr" rid="article-110339.r21">[21]</xref><xref ref-type="bibr" rid="article-110339.r22">[22]</xref><xref ref-type="bibr" rid="article-110339.r23">[23]</xref><xref ref-type="bibr" rid="article-110339.r24">[24]</xref></p>
      </sec>
      <sec id="article-110339.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>In the early inflammatory stage, biopsy specimens of active lesions show perivascular lymphocytic infiltrate with plasma cells in the dermis, telangiectatic endothelial-lined spaces, and mild atrophy of the epidermis. Histological examination of late lesions demonstrates an atrophic epidermis and interstitial lymphocytic infiltrate with plasma cells and occasional histiocytes or mast cells.<xref ref-type="bibr" rid="article-110339.r7">[7]</xref><xref ref-type="bibr" rid="article-110339.r25">[25]</xref></p>
      </sec>
      <sec id="article-110339.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most patients may not recall a tick bite due to the delayed progression of ACA. Furthermore, diagnosis is quite challenging due to varying clinical manifestations. ACA is considered biphasic; it initially presents as bluish-red lesions overlying doughy and swollen skin. It later progresses to extensive skin atrophy with a prominence of underlying blood vessels and a shiny appearance or &#x0201c;cigarette paper skin.&#x0201d; Lesions are primarily located on the bilateral extensor surfaces of the limbs. Fibroid nodules may develop over bony prominences, especially in the ulnar or tibial regions.<xref ref-type="bibr" rid="article-110339.r26">[26]</xref>&#x000a0;In 15% of the patients with ACA, a localized increase of collagen leads to band-like induration with decreased movement of the joints.<xref ref-type="bibr" rid="article-110339.r27">[27]</xref>&#x000a0;Peripheral neuropathy can occur in approximately half of the patients, with associated numbness, tingling, or allodynia.<xref ref-type="bibr" rid="article-110339.r28">[28]</xref>&#x000a0;Enlargement of the limb with tenosynovitis and dactylitis is a rare occurrence.<xref ref-type="bibr" rid="article-110339.r29">[29]</xref><xref ref-type="bibr" rid="article-110339.r30">[30]</xref><xref ref-type="bibr" rid="article-110339.r31">[31]</xref></p>
      </sec>
      <sec id="article-110339.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of ACA is based on clinical findings and supported by serologic tests (high level of specific <italic toggle="yes">Borrelia</italic> IgG antibodies).<xref ref-type="bibr" rid="article-110339.r32">[32]</xref>&#x000a0;Serology is positive for&#x000a0;<italic toggle="yes">Borrelia</italic>&#x000a0;IgG antibodies in most chronic Lyme disease patients. IgM antibodies against <italic toggle="yes">Borrelia</italic> are often false positives in the late stages and thus are not useful in diagnosing ACA.<xref ref-type="bibr" rid="article-110339.r33">[33]</xref>&#x000a0;A negative serologic test excludes ACA. When the clinical picture is uncertain, further diagnosis is made with a skin biopsy and histological examination. Detection of <italic toggle="yes">B. burgdorferi</italic> DNA by culture or PCR helps confirm the diagnosis.<xref ref-type="bibr" rid="article-110339.r5">[5]</xref></p>
      </sec>
      <sec id="article-110339.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The standard management is based on the administration of 1 of the following antibiotics:</p>
        <list list-type="order">
          <list-item>
            <p>Oral amoxicillin 500&#x000a0;to 1000 mg&#x000a0;3 times daily for 14&#x000a0;to 28 days</p>
          </list-item>
          <list-item>
            <p>Oral doxycycline 100 mg twice daily or 200 mg once daily for 14&#x000a0;to 28 days</p>
          </list-item>
          <list-item>
            <p>Intravenous ceftriaxone 2000 mg every 24 hours for 14&#x000a0;to 28 days</p>
          </list-item>
          <list-item>
            <p>Intravenous cefotaxime 2000 mg every 8 hours for 14&#x000a0;to 28 days</p>
          </list-item>
          <list-item>
            <p>Intravenous penicillin G 3&#x000a0;to 4 MU every 4 hours for 14&#x000a0;to 28 days<xref ref-type="bibr" rid="article-110339.r34">[34]</xref><xref ref-type="bibr" rid="article-110339.r35">[35]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-110339.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of ACA depends on the clinical presentation and disease stage. Lesions on the lower extremities are often mistaken as vascular insufficiency (ie, chronic venous or arterial insufficiency, superficial thrombophlebitis), cold injury, livedo reticularis, localized scleroderma, erysipelas, lymphedema, related to chronic use of potent topical corticosteroids or aging. Nodules may be confused with rheumatoid disease, gout, or erythema nodosum.<xref ref-type="bibr" rid="article-110339.r5">[5]</xref></p>
      </sec>
      <sec id="article-110339.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The clinical outcome is positive if the acute inflammatory stage is treated appropriately. The clinical outcome is difficult to predict for the chronic atrophic phase, as changes are only partially reversible. One study showed that third-generation cephalosporin therapy for 28 days resulted in partial dissolving to fade the skin lesion completely.<xref ref-type="bibr" rid="article-110339.r1">[1]</xref><xref ref-type="bibr" rid="article-110339.r36">[36]</xref>&#x000a0;If the skin lesion is left untreated, it does not typically resolve spontaneously, and fibrosis and atrophy can occur. Moreover, antibiotic therapy may not reverse neurologic symptoms, such as polyneuropathy (ie, pain, paresthesia).</p>
      </sec>
      <sec id="article-110339.s12" sec-type="Complications">
        <title>Complications</title>
        <p>ACA&#x000a0;skin lesions may lead to bacterial superinfections. ACA is also considered a risk factor for malignancies, including B-cell lymphoma, basal cell carcinoma, and squamous cell carcinoma.<xref ref-type="bibr" rid="article-110339.r37">[37]</xref></p>
      </sec>
      <sec id="article-110339.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The diagnosis of ACA is often delayed as patients do not report significant symptoms or seek medical attention, and due to the natural history of the disease developing months to years after a tick bite.&#x000a0;Cutaneous lesions in ACA are mostly present on the extremities but may be located in other areas, including the abdomen or face, necessitating serologic and histopathologic confirmation. Treatment should be implemented as early as possible to prevent irreversible skin damage. Lyme borreliosis can be primarily prevented by avoidance of tick bites. Individuals should use personal protective measures to keep them safe when walking in wooded areas. These include applying repellents, wearing long sleeves, tucking pant legs into socks or long boots, and wearing light-colored clothing to make ticks more readily visible.<xref ref-type="bibr" rid="article-110339.r38">[38]</xref>&#x000a0;When returning from the outdoors, changing clothing and examining the body for ticks is crucial. If a tick is found, individuals should use fine-tipped tweezers to grasp the organism as close to the surface of their skin as possible, pull upwards to remove the tick, dispose of it appropriately, and clean the bite area with soap and water. If an individual develops a rash or fever, it is recommended to seek medical care immediately to prevent further sequelae.</p>
      </sec>
      <sec id="article-110339.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Lack of familiarity with&#x000a0;ACA is a major contributor to proper diagnosis and treatment delays. Thus, ACA should be kept on the differential when evaluating skin lesions on the extremities in elderly patients, especially for those with a history of a tick bite. Collaboration between an interprofessional team (dermatologist, rheumatologist, neurologist, cardiologist) is beneficial for patients with multiorgan involvement.</p>
      </sec>
      <sec id="article-110339.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=110339&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=110339">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/acrodermatitis-chronica-atrophicans-lyme-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=110339">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/110339/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=110339">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-110339.s16">
        <title>References</title>
        <ref id="article-110339.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moniuszko-Malinowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Czupryna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dunaj</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pancewicz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garkowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kondrusik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grygorczuk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zajkowska</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acrodermatitis chronica atrophicans: various faces of the late form of Lyme borreliosis.</article-title>
            <source>Postepy Dermatol Alergol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>490</fpage>
            <page-range>490-494</page-range>
            <pub-id pub-id-type="pmid">30429707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scott</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada.</article-title>
            <source>Healthcare (Basel)</source>
            <year>2020</year>
            <month>Jun</month>
            <day>04</day>
            <volume>8</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">32512846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sigal</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Current recommendations for the treatment of Lyme disease.</article-title>
            <source>Drugs</source>
            <year>1992</year>
            <month>May</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>683</fpage>
            <page-range>683-99</page-range>
            <pub-id pub-id-type="pmid">1379147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Strle</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Lyme borreliosis-from tick bite to diagnosis and treatment.</article-title>
            <source>FEMS Microbiol Rev</source>
            <year>2018</year>
            <month>May</month>
            <day>01</day>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-258</page-range>
            <pub-id pub-id-type="pmid">29893904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fingerle</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hunfeld</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Jaulhac</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kaiser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kristoferitsch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ornstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Strle</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Lyme borreliosis: clinical case definitions for diagnosis and management in Europe.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-79</page-range>
            <pub-id pub-id-type="pmid">20132258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hofmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fingerle</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hunfeld</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Huppertz</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ruf</surname>
                <given-names>B</given-names>
              </name>
              <collab>Consensus group</collab>
            </person-group>
            <article-title>Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.</article-title>
            <source>Ger Med Sci</source>
            <year>2017</year>
            <volume>15</volume>
            <fpage>Doc14</fpage>
            <pub-id pub-id-type="pmid">28943834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasudevan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lyme borreliosis and skin.</article-title>
            <source>Indian J Dermatol</source>
            <year>2013</year>
            <month>May</month>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-74</page-range>
            <pub-id pub-id-type="pmid">23723463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGinley-Smith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Dermatoses from ticks.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-92; quiz 393-6</page-range>
            <pub-id pub-id-type="pmid">12963900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhate</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Lyme disease: Part I. Advances and perspectives.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>619</fpage>
            <page-range>619-36; quiz 637-8</page-range>
            <pub-id pub-id-type="pmid">21414493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hub&#x000e1;lek</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Halouzka</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review.</article-title>
            <source>Eur J Epidemiol</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>951</fpage>
            <page-range>951-7</page-range>
            <pub-id pub-id-type="pmid">9476827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glatz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Resinger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Semmelweis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ambros-Rudolph</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>M&#x000fc;llegger</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2015</year>
            <month>May</month>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>565</fpage>
            <page-range>565-71</page-range>
            <pub-id pub-id-type="pmid">25366035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolgemuth</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Flagellar motility of the pathogenic spirochetes.</article-title>
            <source>Semin Cell Dev Biol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>46</volume>
            <fpage>104</fpage>
            <page-range>104-12</page-range>
            <pub-id pub-id-type="pmid">26481969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vig</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Wolgemuth</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Spatiotemporal evolution of erythema migrans, the hallmark rash of Lyme disease.</article-title>
            <source>Biophys J</source>
            <year>2014</year>
            <month>Feb</month>
            <day>04</day>
            <volume>106</volume>
            <issue>3</issue>
            <fpage>763</fpage>
            <page-range>763-8</page-range>
            <pub-id pub-id-type="pmid">24507617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tee</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Escanam&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zuriel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fried</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Massone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cerroni</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Acrodermatitis chronica atrophicans with pseudolymphomatous infiltrates.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2013</year>
            <month>May</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>338</fpage>
            <page-range>338-42</page-range>
            <pub-id pub-id-type="pmid">23147352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buechner</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Rufli</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Erb</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Acrodermatitis chronic atrophicans: a chronic T-cell-mediated immune reaction against Borrelia burgdorferi? Clinical, histologic, and immunohistochemical study of five cases.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1993</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>399</fpage>
            <page-range>399-405</page-range>
            <pub-id pub-id-type="pmid">8095272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parveen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi.</article-title>
            <source>Mol Microbiol</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>1220</fpage>
            <page-range>1220-34</page-range>
            <pub-id pub-id-type="pmid">10712702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brissette</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Bykowski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cooley</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Bowman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Borrelia burgdorferi RevA antigen binds host fibronectin.</article-title>
            <source>Infect Immun</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>77</volume>
            <issue>7</issue>
            <fpage>2802</fpage>
            <page-range>2802-12</page-range>
            <pub-id pub-id-type="pmid">19398540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Norris</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>H&#x000f6;&#x000f6;k</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adherence of Borrelia burgdorferi to the proteoglycan decorin.</article-title>
            <source>Infect Immun</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>63</volume>
            <issue>9</issue>
            <fpage>3467</fpage>
            <page-range>3467-72</page-range>
            <pub-id pub-id-type="pmid">7642279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Koning</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tazelaar</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Hoogkamp-Korstanje</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Elema</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Acrodermatitis chronica atrophicans: a light and electron microscopic study.</article-title>
            <source>J Cutan Pathol</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-32</page-range>
            <pub-id pub-id-type="pmid">7751475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Damage of collagen and elastic fibres by borrelia burgdorferi - known and new clinical and histopathological aspects.</article-title>
            <source>Open Neurol J</source>
            <year>2012</year>
            <volume>6</volume>
            <fpage>179</fpage>
            <page-range>179-86</page-range>
            <pub-id pub-id-type="pmid">23986790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kempf</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kazakov</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>H&#x000fc;bscher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gugerli</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gerbig</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Palmedo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kutzner</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous borreliosis associated with T cell-predominant infiltrates: a diagnostic challenge.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>683</fpage>
            <page-range>683-9</page-range>
            <pub-id pub-id-type="pmid">25617014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zambrano</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Beklemisheva</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Bryksin</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Cabello</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices.</article-title>
            <source>Infect Immun</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>72</volume>
            <issue>6</issue>
            <fpage>3138</fpage>
            <page-range>3138-46</page-range>
            <pub-id pub-id-type="pmid">15155615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yssel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shanafelt</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Soderberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Anzola</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peltz</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis.</article-title>
            <source>J Exp Med</source>
            <year>1991</year>
            <month>Sep</month>
            <day>01</day>
            <volume>174</volume>
            <issue>3</issue>
            <fpage>593</fpage>
            <page-range>593-601</page-range>
            <pub-id pub-id-type="pmid">1831490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grab</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Philipp</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Borrelia burgdorferi possesses a collagenolytic activity.</article-title>
            <source>FEMS Microbiol Lett</source>
            <year>1996</year>
            <month>Oct</month>
            <day>15</day>
            <volume>144</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-45</page-range>
            <pub-id pub-id-type="pmid">8870250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leslie</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Levell</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Cann</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Gilkes</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>Acrodermatitis chronica atrophicans: a case report and review of the literature.</article-title>
            <source>Br J Dermatol</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>131</volume>
            <issue>5</issue>
            <fpage>687</fpage>
            <page-range>687-93</page-range>
            <pub-id pub-id-type="pmid">7999602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zajkowska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Czupryna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pancewicz</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Kondrusik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moniuszko</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acrodermatitis chronica atrophicans.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>10</issue>
            <fpage>800</fpage>
            <pub-id pub-id-type="pmid">21958583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Itin</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>B&#x000fc;chner</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Rufli</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Acrodermatitis chronica atrophicans involving the face. Evidence for Borrelia burgdorferi infection confirmed by DNA amplification.</article-title>
            <source>Dermatology</source>
            <year>1994</year>
            <volume>189</volume>
            <issue>4</issue>
            <fpage>430</fpage>
            <page-range>430-1</page-range>
            <pub-id pub-id-type="pmid">7873838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kristoferitsch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sluga</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Graf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Partsch</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stanek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Budka</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>1988</year>
            <volume>539</volume>
            <fpage>35</fpage>
            <page-range>35-45</page-range>
            <pub-id pub-id-type="pmid">2847621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Molka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jachiet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lepelletier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>de Masson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bagot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bouaziz</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Asymetric red-blue hypertrophic hand and tenosynovitis due to acrodermatitis chronica atrophicans.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2019</year>
            <month>Apr</month>
            <day>01</day>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>655</fpage>
            <pub-id pub-id-type="pmid">30239931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Morruzzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barbarini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sordet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cribier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jaulhac</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lipsker</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Clinical images: toe dactylitis revealing late Lyme borreliosis.</article-title>
            <source>Arthritis Rheum</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>1293</fpage>
            <pub-id pub-id-type="pmid">22275216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaufman</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Gruber</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Benach</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Late cutaneous Lyme disease: acrodermatitis chronica atrophicans.</article-title>
            <source>Am J Med</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>86</volume>
            <issue>6 Pt 2</issue>
            <fpage>828</fpage>
            <page-range>828-30</page-range>
            <pub-id pub-id-type="pmid">2729343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steere</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Strle</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wormser</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Branda</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hovius</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Mead</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Lyme borreliosis.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2016</year>
            <month>Dec</month>
            <day>15</day>
            <volume>2</volume>
            <fpage>16090</fpage>
            <pub-id pub-id-type="pmid">27976670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lj&#x000f8;stad</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Mygland</surname>
                <given-names>&#x000c5;</given-names>
              </name>
            </person-group>
            <article-title>Chronic Lyme; diagnostic and therapeutic challenges.</article-title>
            <source>Acta Neurol Scand Suppl</source>
            <year>2013</year>
            <issue>196</issue>
            <fpage>38</fpage>
            <page-range>38-47</page-range>
            <pub-id pub-id-type="pmid">23190290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flisiak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pancewicz</surname>
                <given-names>S</given-names>
              </name>
              <collab>Polish Society of Epidemiology and Infectious Diseases</collab>
            </person-group>
            <article-title>[Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases].</article-title>
            <source>Przegl Epidemiol</source>
            <year>2008</year>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>193</fpage>
            <page-range>193-9</page-range>
            <pub-id pub-id-type="pmid">18536243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pancewicz</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Garlicki</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Moniuszko-Malinowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zajkowska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kondrusik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grygorczuk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Czupryna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dunaj</surname>
                <given-names>J</given-names>
              </name>
              <collab>Polish Society of Epidemiology and Infectious Diseases</collab>
            </person-group>
            <article-title>Diagnosis and treatment of tick-borne diseases recommendations of the Polish Society of Epidemiology and Infectious Diseases.</article-title>
            <source>Przegl Epidemiol</source>
            <year>2015</year>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>309</fpage>
            <page-range>309-16, 421-8</page-range>
            <pub-id pub-id-type="pmid">26233093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asbrink</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Brehmer-Andersson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hovmark</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acrodermatitis chronica atrophicans--a spirochetosis. Clinical and histopathological picture based on 32 patients; course and relationship to erythema chronicum migrans Afzelius.</article-title>
            <source>Am J Dermatopathol</source>
            <year>1986</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>209</fpage>
            <page-range>209-19</page-range>
            <pub-id pub-id-type="pmid">3728879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leverkus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Finner</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Pokrywka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Franke</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gollnick</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Metastatic squamous cell carcinoma of the ankle in long-standing untreated acrodermatitis chronica atrophicans.</article-title>
            <source>Dermatology</source>
            <year>2008</year>
            <volume>217</volume>
            <issue>3</issue>
            <fpage>215</fpage>
            <page-range>215-8</page-range>
            <pub-id pub-id-type="pmid">18607109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-110339.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhate</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Lyme disease: Part II. Management and prevention.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>639</fpage>
            <page-range>639-53; quiz 654, 653</page-range>
            <pub-id pub-id-type="pmid">21414494</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
